W R Herzog|D Atar - JoVE Visualize

Showing results (61-70 of 140) with videos related to

Pageof 14

Sort By:

Clinical Orthopaedics and Related Research|October 1, 1993

Tarsal navicular position after complete soft-tissue clubfoot releaseD Atar, W B Lehman, A D Grant, et al.

Clinical Orthopaedics and Related Research|October 1, 1994

Minor knee trauma as a possible cause of asymmetrical proximal tibial physis closure. A case reportR Takai, A D Grant, D Atar, et al.

Journal of Pediatric Orthopedics|May 1, 1993

Pavlik harness versus Frejka splint in treatment of developmental dysplasia of the hip: bicenter studyD Atar, W B Lehman, Y Tenenbaum, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989

Nude mice produce a T cell-derived antigen-binding factor that mediates the early component of delayed-type hypersensitivityW R Herzog, R Meade, A Pettinicchi, et al.

Pharmacological Research|July 1, 1997

Bolus magnesium infusion in humans is associated with predominantly unfavourable changes in platelet aggregation and certain haemostatic factorsV L Serebruany, W R Herzog, M L Schlossberg, et al.

The Journal of Biological Chemistry|August 10, 1980

Proline isomerism in the protein folding of ribonuclease AR W Henkens, A D Gerber, M R Cooper, et al.

American Journal of Hematology|April 17, 1998

Plasma fibronectin during myocardial ischemia-reperfusion: effects of magnesium, diltiazem, and a novel Mac-1 inhibitorV L Serebruany, S R Solomon, W R Herzog, et al.

Swiss Medical Weekly|October 31, 2001

Platelet activation as a universal trigger in the pathogenesis of acute coronary events after cocaine abuseK P Callahan, A I Malinin, D Atar, et al.

Journal of Human Hypertension|February 15, 2008

Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular diseaseV L Serebruany, A Malinin, G Barsness, et al.

Clinical Laboratory|October 28, 2011

The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarctionS Ghanavatian, R A Stein, D Atar, et al.

Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:

Pageof 14

Clinical Orthopaedics and Related Research|October 1, 1993

Tarsal navicular position after complete soft-tissue clubfoot releaseD Atar, W B Lehman, A D Grant, et al.

Clinical Orthopaedics and Related Research|October 1, 1994

Minor knee trauma as a possible cause of asymmetrical proximal tibial physis closure. A case reportR Takai, A D Grant, D Atar, et al.

Journal of Pediatric Orthopedics|May 1, 1993

Pavlik harness versus Frejka splint in treatment of developmental dysplasia of the hip: bicenter studyD Atar, W B Lehman, Y Tenenbaum, et al.

Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1989

Nude mice produce a T cell-derived antigen-binding factor that mediates the early component of delayed-type hypersensitivityW R Herzog, R Meade, A Pettinicchi, et al.

Pharmacological Research|July 1, 1997

Bolus magnesium infusion in humans is associated with predominantly unfavourable changes in platelet aggregation and certain haemostatic factorsV L Serebruany, W R Herzog, M L Schlossberg, et al.

The Journal of Biological Chemistry|August 10, 1980

Proline isomerism in the protein folding of ribonuclease AR W Henkens, A D Gerber, M R Cooper, et al.

American Journal of Hematology|April 17, 1998

Plasma fibronectin during myocardial ischemia-reperfusion: effects of magnesium, diltiazem, and a novel Mac-1 inhibitorV L Serebruany, S R Solomon, W R Herzog, et al.

Swiss Medical Weekly|October 31, 2001

Platelet activation as a universal trigger in the pathogenesis of acute coronary events after cocaine abuseK P Callahan, A I Malinin, D Atar, et al.

Journal of Human Hypertension|February 15, 2008

Effects of aliskiren, a renin inhibitor, on biomarkers of platelet activity, coagulation and fibrinolysis in subjects with multiple risk factors for vascular diseaseV L Serebruany, A Malinin, G Barsness, et al.

Clinical Laboratory|October 28, 2011

The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarctionS Ghanavatian, R A Stein, D Atar, et al.

Pageof 14